Citizens Financial Group Inc Guardant Health, Inc. Transaction History

Citizens Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$88.71 - $120.43 $266,218 - $361,410	-3,001 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$98.77 - $132.17 $296,408 - $396,642	3,001 New	3,001 $375,000
Q4 2019 Feb 07, 2020	SELL	$59.49 - $82.78 $773 - $1,076	-13 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$63.94 - $91.11 $831 - $1,184	13 New	13 $1,000

309

110M

2.51M

1.7M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.95B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.